出荷自粛の要請解除 against 一般財団法人化学及血清療法研究所

一般財団法人化学及血清療法研究所 (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareFebruary 26, 2016

Action summary

Company
Original: 一般財団法人化学及血清療法研究所
Corporate Number: 6330005006672
Governing law
Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type
出荷自粛の要請解除
出荷自粛の要請解除
Action date
February 26, 2016
Issuing authority
Ministry of Health, Labour and Welfare
厚生労働省

Violation

Machine-translated summary — verify against original

The Ministry of Health, Labour and Welfare conducted a review of the reported information. Today, at the Infectious Disease Subcommittee of the Health Science Council, based on the attached materials, the results of the review by the Ministry (which concluded there are no discrepancies that would significantly affect quality and safety), and the inventory outlook for similar products from other companies were reported. Opinions were sought on whether to approve the shipment of Kaken Pharmaceutical's 'Enceback Injection' (dry cell culture Japanese encephalitis vaccine). As a result, it was received that, from the perspective of promoting the prevention and control of Japanese encephalitis, shipment should be permitted to avoid supply shortages. Based on these opinions, the Ministry of Health, Labour and Welfare has decided to lift the request for Kaken Pharmaceutical's 'Enceback Injection' (dry cell culture Japanese encephalitis vaccine) to refrain from shipment as of today.

Show original Japanese text

厚生労働省において報告内容の精査を行ってきました。今般、化血研が製造販売する「エンセバック皮下注用」(乾燥細胞培養日本脳炎ワクチン)について、本日の厚生科学審議会感染症部会において、別添資料に基づき、厚生労働省による精査の結果(品質及び安全性等に重大な影響を及ぼす齟齬はないと判断していること)、及び同種の他社製品の今後の在庫見込みを報告し、化血研の製品の出荷を認めるべきかどうかについて意見を伺いました。その結果、当該製品については、日本脳炎の発生の予防及びまん延の防止を推進する観点から、出荷を認め、供給不足を避けるべきと考えられる、との意見をいただきました。厚生労働省においては、当該意見等を踏まえ、本日付で、化血研の「エンセバック皮下注用」(乾燥細胞培養日本脳炎ワクチン)の出荷自粛の要請を解除することとしましたので、お知らせいたします。

Source

Original Ministry of Health, Labour and Welfare announcement (in Japanese)

The original Japanese disclosure is the authoritative record.

Watch this company

Get an email when 一般財団法人化学及血清療法研究所 has new enforcement actions or registry changes (representative, address, business status). Sign-in is via a one-time email link — no password.

Company info

English name
一般財団法人化学及血清療法研究所 Japanese only
Japanese name
一般財団法人化学及血清療法研究所
Corporate Number
6330005006672
Registered address
熊本県熊本市中央区新市街8番7号
See company profile →

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.